Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Takeda Pharmaceutical (Respiratory Business)

M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of pharmaceutical for respiratory treatments. The company develops and distributes respiratory medicines and early pipeline products. It also supplies respiratory products, including Alvesco and Omnaris, a steroid that reduces inflammation.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 4-1-1 Dosho-machi
  • Chuo-ku Osaka City
  • Osaka, 540-8645
  • Japan

Takeda Pharmaceutical (Respiratory Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Takeda Pharmaceutical (Respiratory Business)‘s full profile, request access.

Request full access to PitchBook

Takeda Pharmaceutical (Respiratory Business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Takeda Pharmaceutical (Respiratory Business)‘s full profile, request access.

Request full access to PitchBook